CASP3 and medullary thyroid gland carcinoma: As indicated in Table 3, after treatment with Furanodiene at 1/9 MTC, 1/3 MTC and MTC, caspase-3/7, -8 and -9 activities were all notably increased by (2 ± 1.78)%, (16 ± 1.47)% and (67 ± 1.66)%; (11 ± 1.56)%, (17 ± 1.46)% and (68 ± 2.17)%; and (8 ± 1.69)%, (17 ± 2.31)% and (69 ± 2.85)%, respectively.